文献速递食管与纵隔外科

机器人胸腺切除术与经胸骨胸腺切除术治疗早期胸腺瘤的比较:倾向性评分匹配研究

Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

该回顾性研究纳入1982年至2017年164例早期胸腺瘤(Masaoka I和II期)患者,比较经胸骨(108例)与机器人(56例)胸腺切除术。机器人组手术时间更长但术中出血更少、围术期并发症更少、胸管引流和住院时间更短、总费用更低,肿瘤学结果无差异,但经胸骨组随访时间显著更长。

要点

  • 机器人胸腺切除术治疗早期胸腺瘤技术安全可行,并发症率低、住院时间短。
  • 机器人组手术时间显著更长,但术中出血、围术期并发症、胸管引流时间和住院时间均更少或更短。
  • 机器人组总费用显著低于经胸骨组,主要因住院时间缩短;肿瘤复发无差异,但经胸骨组随访更长。

核心结论

  • 机器人胸腺切除术治疗早期胸腺瘤是技术安全可行的术式,相比经胸骨入路并发症率低、住院时间短。
  • 费用分析显示机器人手术因住院时间缩短而费用更低。
  • 肿瘤学结果似乎相当,但需要更长的随访。

研究设计与样本

  • 回顾性研究,纳入1982年至2017年164例早期胸腺瘤(Masaoka I和II期)患者,经胸骨组108例,机器人组56例。
  • 评估手术时间、出血量、并发症、胸管引流时间、术后住院时间、肿瘤学结果和总费用,并进行倾向性评分匹配后分析。

主要发现

  • 机器人组平均手术时间显著长于经胸骨组(P < 0.001)。
  • 机器人组术中出血量少于经胸骨组(P = 0.01),围术期并发症少于经胸骨组(P = 0.03)。
  • 机器人组胸管引流拔除时间和出院时间均短于经胸骨组(P < 0.001)。
  • 经胸骨组中位费用显著高于机器人组(P < 0.001),主要因住院时间更长。
  • 胸腺瘤复发无差异,但经胸骨组随访时间显著更长(P < 0.001);倾向性评分匹配后数据得到证实。

临床怎么用

  • 作者认为机器人胸腺切除术治疗早期胸腺瘤是技术安全可行的术式,相比经胸骨入路并发症率低、住院时间短。
  • 作者指出机器人手术因住院时间缩短而费用更低,肿瘤学结果似乎相当,但需要更长随访。

局限性

  • 经胸骨组随访时间显著长于机器人组(P < 0.001)。
  • 原文结论指出需要更长的随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Minimally invasive techniques seem to be promising alternatives to open approaches in the surgical treatment of early-stage thymoma, although there are controversies because of lack of data on long-term results. The aim of the study was to evaluate the surgical and oncological results after robotic thymectomy for early-stage thymoma compared to median sternotomy. METHODS: Between 1982 and 2017, 164 patients with early-stage thymoma (Masaoka I and II) were operated on by median sternotomy (108 patients) or the robotic approach (56 patients). Duration of surgery, amount of blood loss, complications, duration of chest drainage, postoperative hospital stay, oncological results and total costs were retrospectively evaluated. Data were analysed also after propensity score matching. RESULTS: Compared to the trans-sternal group, robotic thymectomy had significantly longer average operative times (P < 0.001) but less intraoperative blood loss (P = 0.01), less perioperative complications (P = 0.03), shorter time to chest drainage removal and hospital discharge (P < 0.001). The median expense for the trans-sternal approach was significantly higher than the cost of the robotic procedure (P < 0.001), mainly due to longer hospitalization. From an oncological point of view, there were no differences in thymoma recurrence, although follow-up of the trans-sternal group was significantly longer (P < 0.001). Data were confirmed after propensity score matching. CONCLUSIONS: Robotic thymectomy for early-stage thymoma is a technically safe and feasible procedure with low complication rate and shorter hospital stay compared to the trans-sternal approach. Cost analysis revealed lower expenses for the robotic procedure due to the reduced hospital stay. The oncological outcomes seemed comparable, but longer follow-up is needed.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Marulli G, Comacchio GM, Schiavon M, et al. Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study. Eur J Cardiothorac Surg. 2018. PMID: 29547970. doi:10.1093/ejcts/ezy075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。